Toronto, Canada
Joeyband™ is a Canadian-based health care startup with a mission to transform the practice of skin-to-skin care for newborns. The company offers a globally patented, FDA registered class 1 device for skin-to-skin contact during c-section, NICU, postpartum, and home care. Supported by data from renowned hospitals, including Ivy League Institutions, the device has shown significant health benefits for both infants and parents. These include a reduction in infant falls and NICU admissions, decreased maternal anxiety, improved exclusive breastfeeding rates, and enhanced patient satisfaction.
The Joeyband™ device is the sole FDA registered class 1 medical device designed for use on the Operating Room table, NICU, and Labor & Delivery units, providing a versatile solution for various care settings. The startup has gained recognition from prestigious organizations, such as being named the exclusive skin-to-skin product of La Leche League International (LLLI) and receiving accolades from the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN).
Since its establishment in 2012, Joeyband™ has been committed to reshaping the standard of care for newborns, garnering positive reviews and winning prestigious awards, including the PTPA and recognition from the Family Review Center.
As of now, there is no public information regarding the last investment or the involved investors.
